The aim of this study was to characterise the commonalities and differences of the tau protein in post-mortem-confirmed brain tissue of AD, PSP, CBD, PiD, and control cases in both soluble and insoluble brain homogenates. The gene discussed is MAPT; the disease is Alzheimer disease.